Literature DB >> 20824454

Osteochondral diseases and fibrodysplasia ossificans progressiva.

Antonio Morales-Piga1, Frederick S Kaplan.   

Abstract

Osteochondrodysplasias like thanatophoric dysplasia, osteogenesis imperfecta, achondroplasia, and other genetic skeletal disorders like fibrodysplasia ossificans progressiva are infrequently seen in clinical practice. In cases of sporadic achondroplasia as well as in fibrodysplasia ossificans progressiva, there is a strong association with paternal age, a relationship that is less evident in other genetic osteochondral diseases. No other constitutional or environmental factor has proven to be associated with these disorders. The use of prenatal ultrasonography as a routine component of prenatal care is crucial in the early suspicion of osteochondrodysplasias whereas definitive diagnosis is usually obtained by pre-natal molecular analysis. In the case of fibrodysplasia ossificans progressiva, recognition of congenital great toe malformations associated with rapidly-appearing soft tissue swelling is sufficient to make the proper clinical diagnosis, which can be confirmed by genetic testing. Large regional centres will improve diagnosis performance, provide accurate genetic counselling, and ensure an integral assistance for these often severe and incapacitating conditions.

Entities:  

Mesh:

Year:  2010        PMID: 20824454      PMCID: PMC4913786          DOI: 10.1007/978-90-481-9485-8_19

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  36 in total

1.  [Prevalence of bone dysplasias in newborns at the Ruíz y Páez Hospital in Bolívar City. Venezuela. 1978-1990].

Authors:  O Sánchez; A Brito-Arreaza; M C Alvarez-Arratia; N Ramírez
Journal:  Invest Clin       Date:  1991       Impact factor: 0.683

2.  Prevalence of lethal osteochondrodysplasias in Denmark.

Authors:  P E Andersen
Journal:  Am J Med Genet       Date:  1989-04

3.  Birth prevalence rates of skeletal dysplasias.

Authors:  C Stoll; B Dott; M P Roth; Y Alembik
Journal:  Clin Genet       Date:  1989-02       Impact factor: 4.438

4.  Prenatal diagnosis of diastrophic dysplasia with polymorphic DNA markers.

Authors:  J Hästbacka; R Salonen; P Laurila; A de la Chapelle; I Kaitila
Journal:  J Med Genet       Date:  1993-04       Impact factor: 6.318

5.  Epidemiology of osteochondrodysplasias: changing trends due to advances in prenatal diagnosis.

Authors:  S A Rasmussen; F R Bieber; B R Benacerraf; R S Lachman; D L Rimoin; L B Holmes
Journal:  Am J Med Genet       Date:  1996-01-02

6.  The birth prevalence rates for the skeletal dysplasias.

Authors:  I M Orioli; E E Castilla; J G Barbosa-Neto
Journal:  J Med Genet       Date:  1986-08       Impact factor: 6.318

7.  The population-based prevalence of achondroplasia and thanatophoric dysplasia in selected regions of the US.

Authors:  D K Waller; A Correa; Tuan M Vo; Y Wang; C Hobbs; P H Langlois; K Pearson; P A Romitti; G M Shaw; J T Hecht
Journal:  Am J Med Genet A       Date:  2008-09-15       Impact factor: 2.802

8.  Lethal neonatal chondrodysplasias in the West of Scotland 1970-1983 with a description of a thanatophoric, dysplasialike, autosomal recessive disorder, Glasgow variant.

Authors:  J M Connor; R A Connor; E M Sweet; A A Gibson; W J Patrick; M B McNay; D H Redford
Journal:  Am J Med Genet       Date:  1985-10

Review 9.  Inherited disorders of collagen gene structure and expression.

Authors:  P H Byers
Journal:  Am J Med Genet       Date:  1989-09

Review 10.  Fibrodysplasia ossificans progressiva.

Authors:  Frederick S Kaplan; Martine Le Merrer; David L Glaser; Robert J Pignolo; Robert E Goldsby; Joseph A Kitterman; Jay Groppe; Eileen M Shore
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-03       Impact factor: 4.098

View more
  5 in total

Review 1.  Fibrodysplasia ossificans progressiva: diagnosis, management, and therapeutic horizons.

Authors:  Robert J Pignolo; Eileen M Shore; Frederick S Kaplan
Journal:  Pediatr Endocrinol Rev       Date:  2013-06

2.  The Natural History of Flare-Ups in Fibrodysplasia Ossificans Progressiva (FOP): A Comprehensive Global Assessment.

Authors:  Robert J Pignolo; Christopher Bedford-Gay; Moira Liljesthröm; Blythe P Durbin-Johnson; Eileen M Shore; David M Rocke; Frederick S Kaplan
Journal:  J Bone Miner Res       Date:  2015-11-14       Impact factor: 6.741

3.  Suppressed prefrontal cortex oscillations associate with clinical pain in fibrodysplasia ossificans progressiva.

Authors:  Ke Peng; Keerthana Deepti Karunakaran; Robert Labadie; Miranda Veliu; Chandler Cheung; Arielle Lee; Paul B Yu; Jaymin Upadhyay
Journal:  Orphanet J Rare Dis       Date:  2021-01-30       Impact factor: 4.123

4.  Fibrodysplasia ossificans progressiva in a young adult with genetic mutation: Case report.

Authors:  Zhankui Wang; Xiuhua Wang; Baojin Liu; Yanfeng Hou
Journal:  Medicine (Baltimore)       Date:  2021-03-05       Impact factor: 1.817

5.  [Is there a place in primary care for rare diseases? The case of fibrodysplasia ossificans progressiva].

Authors:  Antonio Morales-Piga; Miguel García Ribes; Pilar Arribas Álvaro; Carlos Casado Álvaro; Manuel Posada de La Paz; Javier Bachiller-Corral
Journal:  Aten Primaria       Date:  2013-01-28       Impact factor: 1.137

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.